Stock listing
Akeso, Inc.
- Ticker
- Lang & Schwarz: A2P200
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
Latest news from Akeso, Inc.
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2026
Oct 7, 2026
2026 Interim report
Sep 30, 2026
Akeso Announces First Patient Enrolled in Global Phase III Trial of Cadonilimab Versus Nivolumab in First-Line Gastric Cancer
Sep 27, 2026
Ivonescimab First-Line Biliary Tract Cancer Phase III Overall Survival Data Selected as ESMO Late-Breaking Abstract; Nearly 30 Akeso Studies to Be Presented at ESMO 2026
Sep 21, 2026